摘要
目的:探讨P16在不同宫颈病变组织中的表达及在临床诊断中的应用价值。方法:选择慢性宫颈炎19例,各级别宫颈上皮内瘤变(CIN)89例(CINⅠ35例,CINⅡ30例,CINⅢ24例)及宫颈鳞状细胞癌7例,采用免疫组化技术检测P16在各组患者的表达水平。结果:P16在慢性宫颈炎、CINⅠ、CINⅡ、CINⅢ及宫颈鳞状细胞癌组患者的阳性表达率分别为0.00%、40.00%、66.67%、70.83%、100.00%,随宫颈病变程度的升级P16蛋白的表达率及阳性表达强度均逐渐上升,差异有统计学意义(P<0.05)。结论:P16用于鉴别不同级别宫颈上皮内瘤变指异临床诊疗有重要价值。
Objective: To explore the expressions of P16 in various cervical lesions tissues and its application value in clinical diagnosis. Methods: Nineteen patients with chronic cervicitis,eighty- nine patients with cervical intraepithelial neoplasia( CIN)( 35 patients with CINⅠ,30 patients with CINⅡ,and 24 patients with CINⅢ),and seven patients with cervical squamous cell carcinoma were enrolled in the study; immunohistochemical technology was used to detect the expression levels of P16 in different groups. Results: The positive expression rates of P16 in chronic cervicitis,CINⅠ,CINⅡ,CINⅢ,and cervical squamous cell carcinoma were 0. 00%,40. 00%,66. 67%,70. 83%,and 100. 00%,respectively. The expression rate and positive expression intensity of P16 increased gradually with the aggravation of cervical lesions,there were statistically significant differences( P〈0. 05). Conclusion: P16 is used to identify different grades of CIN,which has an important value in guiding clinical diagnosis and treatment.
出处
《中国妇幼保健》
CAS
2015年第18期2944-2945,共2页
Maternal and Child Health Care of China